scispace - formally typeset
J

Jacopo Desiderio

Researcher at University of Perugia

Publications -  90
Citations -  2393

Jacopo Desiderio is an academic researcher from University of Perugia. The author has contributed to research in topics: Robotic surgery & Cancer. The author has an hindex of 23, co-authored 85 publications receiving 1964 citations. Previous affiliations of Jacopo Desiderio include Sapienza University of Rome & Medical University of Graz.

Papers
More filters
Journal ArticleDOI

Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials

TL;DR: LSG is a well-tolerated, feasible procedure with a relatively short operating time, and its effectiveness in terms of weight loss is confirmed for short-term follow-up (≤ 3 years) and the role of LSG in the treatment of T2DM requires further investigation.
Journal ArticleDOI

Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis.

TL;DR: Although colonic stenting appears to be an effective treatment of malignant large bowel obstruction, the clinical success resulted significantly higher in the emergency surgery group without any advantages in terms of overall complication rate and 30-days postoperative mortality.
Journal ArticleDOI

Systematic review and meta-analysis of randomized clinical trials comparing single-incision versus conventional laparoscopic cholecystectomy.

TL;DR: Single‐incision laparoscopic cholecystectomy (SILC) may offer advantages over conventional laparoscopies (LC) in women and men with certain medical conditions.
Journal ArticleDOI

The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer

TL;DR: This study demonstrates a survival advantage of the use of HIPEC as a prophylactic strategy and suggests that patients whose disease burden is limited to positive cytology and limited nodal involvement may benefit the most from HIPEC.